HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

gadobenic acid (gadobenate dimeglumine)

used in MR imaging of liver
Also Known As:
gadobenate dimeglumine; 3,6,9-triaza-12-oxa-3,6,9-tricarboxymethylene-10-carboxy-13-phenyltridecanoic acid, gadolinium; Altana Pharma brand of gadobenic acid, dimeglumine salt; B 19036; B-19036; Gd-BOPTA; MultiHance; gadobenic acid, dimeglumine salt; gadolinium-BOPTA-Dimeg; gadolinium-benzyloxypropionyl tetraacetate
Networked: 247 relevant articles (23 outcomes, 42 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Kirchin, Miles A: 24 articles (12/2015 - 03/2002)
2. Pirovano, Gianpaolo: 12 articles (09/2015 - 03/2002)
3. Catalano, Carlo: 12 articles (12/2014 - 10/2005)
4. Kirchin, M A: 10 articles (09/2015 - 01/2000)
5. Passariello, Roberto: 10 articles (02/2012 - 10/2005)
6. Spinazzi, Alberto: 8 articles (09/2015 - 12/2002)
7. Essig, Marco: 8 articles (06/2011 - 01/2004)
8. Schneider, Günther: 8 articles (02/2011 - 12/2002)
9. Pirovano, G: 7 articles (09/2015 - 01/2000)
10. Pediconi, Federica: 7 articles (05/2014 - 10/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Brain Neoplasms (Brain Tumor)
4. Hepatocellular Carcinoma (Hepatoma)
5. Breast Neoplasms (Breast Cancer)
06/01/2005 - "Gadobenate dimeglumine is effective for MR imaging evaluation of breast vessels at doses as low as 0.05 mmol/kg. One-sided increased vascularity is an MR imaging finding frequently associated with ipsilateral invasive breast cancer."
07/07/2015 - "[Controlled study of gadobenate dimeglumine versus gadopentetate in breast tumor MR dynamic enhancement scanning]."
02/01/2011 - "Readers 1, 2, and 3 reported significantly superior diagnostic performance (sensitivity, specificity, and accuracy) for breast cancer detection with gadobenate dimeglumine (91.1%, 94.5%, 95.2% vs 81.2%, 82.6%, 84.6%; 99.0%, 98.2%, 96.9% vs 97.8%, 96.9%, 93.8%; 98.2%, 97.8%, 96.7% vs 96.1%, 95.4%, 92.8%, respectively; P ≤ .0094) and significantly superior PPV (91.1%, 85.2%, 77.2% vs 80.7%, 75.5%, 60.9%, respectively; P ≤ .0002) and NPV (99.0%, 99.4%, 99.4% vs 97.8%, 98.0%, 98.1%, respectively; P ≤ .0003). "
07/01/2009 - "Two hundred thirty-eight women with dense breast parenchyma who were suspicious for breast cancer or inconclusive for the presence of breast lesions based on clinical examination, ultrasound or x-ray mammography, and who underwent breast MRI at 1.5 T before and after administration of 0.1 mmol/kg gadobenate dimeglumine were evaluated. "
11/01/2007 - "A total of 164 women with suspected breast cancer based on clinical examination, conventional mammography and/or ultrasound each underwent preoperative bilateral CE-MRM using an axial 3D dynamic T1-weighted gradient-echo sequence and gadobenate dimeglumine as contrast agent. "

Related Drugs and Biologics

1. gadobenic acid (gadobenate dimeglumine)
2. Gadolinium DTPA (Magnevist)
3. Gadolinium
4. Contrast Media
5. gadobutrol
6. gadodiamide (Omniscan)
7. N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)
8. glucuronyl glucosamine glycan sulfate (Vessel)
9. ferric oxide (iron oxide)
10. gadolinium ethoxybenzyl DTPA

Related Therapies and Procedures

1. Renal Replacement Therapy (Therapies, Renal Replacement)
2. Liver Transplantation
3. Injections
4. Intravenous Injections
5. Endovascular Procedures